Natures Sunshine Products Inc SEC filings NATR
Natures Sunshine Products Inc has 1,002 filings in SEC EDGAR's recent list, going back to Jun 21, 2011. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| EFFECT | Filing | Apr 22, 2024 | — |
| EFFECT | Filing | Aug 2, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2016 | — |
| CORRESP | Letter to the SEC | Apr 7, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2015 | — |
| CORRESP | Letter to the SEC | Jul 24, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2015 | — |
| 11-K | Employee savings plan report | Jun 30, 2014 | Dec 31, 2013 |
| 11-K | Employee savings plan report | Jun 28, 2013 | Dec 31, 2012 |
| UPLOAD | Letter from the SEC | Jul 24, 2012 | — |
| CORRESP | Letter to the SEC | Jun 29, 2012 | — |
| 11-K | Employee savings plan report | Jun 27, 2012 | Dec 31, 2011 |
| UPLOAD | Letter from the SEC | Jun 15, 2012 | — |
| 11-K | Employee savings plan report | Jun 28, 2011 | Dec 31, 2010 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NATR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- Lehi, UT
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 275053
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.